Barely Significant
← all excerpts

The Effect of Protease-Activated Receptor-1 (PAR-1) Inhibition on Endothelial-Related Biomarkers in Patients with Coronary Artery Disease.

Thromb Haemost · 2023 · PMC10113036 · PMID 36588289

Europe PMCDOI
1
hedged sentence
0.0500
closest p · 1.0× alpha
0.0500
boldest claim

The sentences

borderline significantp = 0.05actually significant
rvention with vorapaxar as compared with placebo. PAI-2 decreased significantly in favor of vorapaxar as compared with placebo in the total study population ( p = 0.025) at late FU, essentially driven by changes in the post-MI (chronic CHD) patients ( p = 0.054), whereas vorapaxar induced a borderline significant increase ( p = 0.05) in NSTEMI (TRACER) patients during short-term therapy ( Table 6 ).

also in 2,000 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.